Teva Pharmaceutical ( Teva Pharmaceutical)

Primary tabs

Teva Pharmaceutical's picture

Management

Contact Address

About Teva Pharmaceutical

The foundation of our success, and at the heart of Teva, is our vision to be the most indispensable medicines company for the world, executing on our obligation to our patients, customers, shareholders and employees. Established in 1901, today we rank among the 10 top pharmaceutical companies in the world. Headquartered in Israel, Teva is active in 60 countries, with over 46,400 dedicated employees worldwide.

Teva Pharmaceutical press release, blog etc

Fri, 05/17/2024 - 00:03 Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
Mon, 03/14/2022 - 14:11 Teva Announces Donations of Essential Medicines in Support of Ukrainian Refugees
Thu, 12/30/2021 - 12:40 Teva Statement Following New York Jury Ruling in Opioids Trial
Mon, 11/01/2021 - 14:19 New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to Impending Relapse Compared to Placebo in Patients with Schizophrenia
Tue, 10/26/2021 - 21:59 Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes
Thu, 08/12/2021 - 17:19 Showcasing Tevas Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY (fremanezumab-vfrm) Injection at the International Headache Society and European Headache...
Wed, 07/21/2021 - 03:38 Teva Announces Changes to Executive Management Team
Tue, 06/09/2020 - 04:34 Teva Announces Virtual 2020 Annual Meeting of Shareholders
Mon, 05/04/2020 - 11:08 Teva and Celltrion Healthcare Announce the Launch of TRUXIMA (rituximab-abbs) Injection for Rheumatoid Arthritis, the Only Biosimilar to Rituxan (rituximab) Available in the United States for This Indication
Fri, 05/01/2020 - 09:45 New Data For Teva AJOVY (fremanezumab-vfrm) Injection and AUSTEDO (deutetrabenazine) Tablets Included in Neurology
Mon, 04/27/2020 - 11:38 Teva Announces U.S. Launch of Autoinjector for AJOVY (fremanezumab-vfrm) Injection
Thu, 03/19/2020 - 20:58 Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide
Mon, 03/16/2020 - 12:54 Teva and Celltrion Healthcare Announce U.S. Availability of HERZUMA (trastuzumab-pkrb) for Injection
Thu, 03/12/2020 - 07:44 Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY (fremanezumab)
Thu, 03/12/2020 - 01:22 Positive Empfehlung des NICE fur die erste, gegen das CGRP gerichtete Migranetherapie: AJOVY (Fremanezumab)
Thu, 03/12/2020 - 01:12 Avis favorable de l'Institut national pour l'excellence clinique (NICE) pour le premier traitement anti-PRGC de la migraine : AJOVY (fremanezumab)
Mon, 02/24/2020 - 02:20 Teva Announces FDA Approval of ArmonAir Digihaler (fluticasone propionate) Inhalation Powder
Wed, 02/19/2020 - 05:06 Teva Announces Registration Trials of Deutetrabenazine in Pediatric Patients with Tourette Syndrome Did Not Meet the Primary Endpoint